No Data
No Data
Express News | Incannex Healthcare Inc Files for Offering 4 Mln Common Shares Together With Common Warrants to Purchase up to 4 Mln Common Shares - SEC Filing
Express News | Patient Dosing Commenced in Reposa Phase 2/3 Clinical Trial Protocol to Assess Ihl-42X Drug in Patients With Obstructive Sleep Apnea
Why Incannex Healthcare's (NASDAQ:IXHL) Earnings Are Weaker Than They Seem
10-Q: Quarterly report
FDA Experts Weigh In On Incannex's CannQuit-O With Feedback On CBD As Treatment For Opioid Use Disorder
Incannex Complete Successful Pre-IND Meeting With the FDA for CannQuit-O for Treatment of Opioid Use Disorder
No Data